Skip to main content
Clinical Trials/ISRCTN84968882
ISRCTN84968882
Completed
Phase 4

A single-centre randomised controlled trial of propofol cardioplegia on blood and myocardial biomarkers of stress and injury in patients having isolated coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) using cardiopulmonary bypass (CPB)

niversity Hospitals Bristol NHS Foundation Trust (UK)0 sites96 target enrollmentNovember 11, 2009

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity Hospitals Bristol NHS Foundation Trust (UK)
Enrollment
96
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Registry
who.int
Start Date
November 11, 2009
End Date
December 31, 2016
Last Updated
7 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Hospitals Bristol NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 01/02/2011:
  • 1\. Male or female
  • 2\. Age \=18 to \=80 years
  • 3\. Having elective or urgent CABG or AVR with CPB at the BHI
  • 4\. Able to give full informed consent for the study
  • Previous inclusion criteria:
  • 1\. Male or female
  • 2\. Aged greater than or equal to 16 years to less than or equal to 80 years
  • 3\. Having elective or urgent CABG or AVR with CPB at the Bristol Heart Institute (BHI)
  • 4\. Able to give full informed consent for the study

Exclusion Criteria

  • Current inclusion criteria as of 01/02/2011:
  • 1\. Previous cardiac surgery
  • 2\. Combined CABG and AVR
  • 3\. Emergency or salvage operation
  • 4\. Chronic renal failure requiring dialysis
  • 5\. Current congestive heart failure
  • 6\. Left ventricular ejection fraction less than 30% (i.e. poor LV function)
  • 7\. Allergy to peanuts, eggs, egg products, soybeans or soy products
  • 8\. Already participating in another clinical (interventional) study
  • Previous inclusion criteria:

Outcomes

Primary Outcomes

Not specified

Similar Trials